MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Abbott Laboratories

Fermé

SecteurSoins de santé

131.66 -0.32

Résumé

Variation du prix de l'action

24h

Actuel

Min

131.22

Max

133.52

Chiffres clés

By Trading Economics

Revenu

7.6B

9.2B

Ventes

339M

11B

P/E

Moyenne du Secteur

17.363

63.778

BPA

1.34

Rendement du dividende

1.78

Marge bénéficiaire

84.099

Employés

114,000

EBITDA

82M

3B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+6.28% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.78%

2.39%

Prochains Résultats

16 avr. 2025

Date du Prochain Dividende

15 mai 2025

Date du Prochain Détachement de Dividende

15 avr. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

7.8B

230B

Ouverture précédente

131.98

Clôture précédente

131.66

Sentiment de l'Actualité

By Acuity

27%

73%

81 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Abbott Laboratories Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 janv. 2025, 19:03 UTC

Résultats

Correction to Abbott Labs 4Q Sales Just Miss Estimates Article

22 janv. 2025, 18:20 UTC

Résultats

Abbott Labs 4Q Sales Just Miss Estimates; Shares Rise on 2025 Outlook -- Update

22 janv. 2025, 12:45 UTC

Résultats

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

1 nov. 2024, 14:15 UTC

Principaux Mouvements du Marché

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win -- Update

1 nov. 2024, 10:10 UTC

Principaux Mouvements du Marché

Reckitt Shares Surge After Baby Formula Lawsuit Win

31 oct. 2024, 23:57 UTC

Actions en Tendance

Stocks to Watch: Intel, Amazon.com, Abbott Laboratories, MasTec

31 oct. 2024, 23:14 UTC

Principaux Mouvements du Marché

Abbott Laboratories Shares Rise After Baby-Formula Verdict

16 oct. 2024, 12:03 UTC

Résultats

Abbott Laboratories 3Q Sales Top Expectations

1 févr. 2025, 18:14 UTC

Actualités

Musk's X Adds Nestlé, Colgate, Shell, Other Brands to Ad-Boycott Suit -- WSJ

22 janv. 2025, 16:40 UTC

Actualités
Résultats

Abbott Laboratories Stock Turns Positive. What to Know From Its Earnings. -- Barrons.com

22 janv. 2025, 15:20 UTC

Résultats

Abbott Laboratories Posts 'Middling' Quarter, But Diabetes Devices Shine -- IBD

22 janv. 2025, 15:08 UTC

Résultats

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 janv. 2025, 13:51 UTC

Résultats

Abbott Laboratories Slides On Light Fourth-Quarter Sales, In-Line Profit -- IBD

22 janv. 2025, 13:39 UTC

Actualités
Résultats

Abbott Laboratories Stock Falls After Earnings as Sales Miss Estimates -- Barrons.com

22 janv. 2025, 12:02 UTC

Résultats

Abbott Labs Sees 1Q Adj EPS $1.05-Adj EPS $1.09 >ABT

22 janv. 2025, 12:01 UTC

Résultats

Abbott Labs Sees 2025 Adj EPS $5.05-Adj EPS $5.25 >ABT

22 janv. 2025, 12:01 UTC

Résultats

Abbott Labs Sees 2025 Adjusted Operating Margin 23.5%-24% >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs Sees 2025 Organic Sales Growth 7.5%-8.5% >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs 4Q Net $9.23B >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs 4Q Sales $10.97B >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs 4Q Organic Sales Growth Up 8.8% >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs 4Q EPS $5.27 >ABT

22 janv. 2025, 12:00 UTC

Résultats

Abbott Labs 4Q Adj EPS $1.34 >ABT

22 janv. 2025, 09:54 UTC

Actions en Tendance

Stocks to Watch Wednesday: Netflix, Oracle, Trump Media, Softbank -- WSJ

1 nov. 2024, 17:33 UTC

Market Talk

Abbott's Baby-Formula Lawsuit Win Could Decrease Liabilities -- Market Talk

16 oct. 2024, 14:21 UTC

Actualités
Résultats

Abbott Posts Solid Quarter. The Stock Is Rising. -- Barrons.com

16 oct. 2024, 12:25 UTC

Résultats

Abbott Labs Beats Q3 Sales And Earnings Expectations, Raises Full-Year Outlook -- MarketWatch

16 oct. 2024, 12:02 UTC

Actualités
Résultats

Abbott Posts Solid Quarter. That Wasn't Enough to Lift Shares. -- Barrons.com

16 oct. 2024, 11:59 UTC

Résultats

Abbott Earnings Edge Past Q3 Views, Led By Medical Devices -- IBD

16 oct. 2024, 11:37 UTC

Résultats

Abbott Labs Sees 4Q Adj EPS $1.31-Adj EPS $1.37 >ABT

Comparaison

Variation de prix

Abbott Laboratories prévision

Objectif de Prix

By TipRanks

6.28% hausse

Prévisions sur 12 Mois

Moyen 140.21 USD  6.28%

Haut 158 USD

Bas 117 USD

Basé sur 16 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

16 ratings

14

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

126.38 / 132.65Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Strong Bullish Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

81 / 386Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.